<DOC>
	<DOCNO>NCT00592839</DOCNO>
	<brief_summary>This multi-center study evaluate effect SCE-B nocturnal vasomotor symptom . Study duration approximately 16 week ; include 4-week screening period approximately 5 schedule clinic visit . Participants receive one two strengths SCE-B tablet plus match placebo placebo , physical gynecological exam may include transvaginal ultrasound , endometrial biopsy pap smear . Participants ask wear monitoring device portion study ask complete daily dairy .</brief_summary>
	<brief_title>Study Evaluate Effects Synthetic Conjugated Estrogens , B ( SCE-B ) Nocturnal Vasomotor Symptoms Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estrogens , conjugate synthetic B</mesh_term>
	<mesh_term>Estrogens , conjugate synthetic A</mesh_term>
	<criteria>Naturally surgically menopausal Minimum 7 daily 50 weekly moderatetosevere hot flash Any contraindication hormone therapy</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Nocturnal vasomotor symptom postmenopausal woman</keyword>
</DOC>